Glomerulonephritis

Publication Title: 
Pediatric Emergency Care

OBJECTIVE: The study's objective was to report a case and review the literature on the use of extracorporeal life support in the face of severe pulmonary hemorrhage for acute respiratory distress syndrome. STUDY SELECTION: This study is a single case report of a pediatric patient who was successfully managed on venovenous extracorporeal life support for severe acute respiratory distress syndrome with acute pulmonary hemorrhage secondary to Wegener disease.

Author(s): 
Joseph, Mark
Charles, Anthony G.
Publication Title: 
Journal of Dental Research

Discoveries of immunomodulatory functions in mesenchymal stem cells (MSCs) have suggested that they might have therapeutic utility in treating immune diseases. Recently, a novel MSC population was identified from dental pulp of human supernumerary teeth, and its multipotency characterized. Herein, we first examined the in vitro and in vivo immunomodulatory functions of human supernumerary tooth-derived stem cells (SNTSCs).

Author(s): 
Makino, Y.
Yamaza, H.
Akiyama, K.
Ma, L.
Hoshino, Y.
Nonaka, K.
Terada, Y.
Kukita, T.
Shi, S.
Yamaza, T.
Publication Title: 
British Medical Journal
Author(s): 
Preston, F. E.
Malia, R. G.
Blackburn, E. K.
Platts, M.
Publication Title: 
PloS One

BACKGROUND: Artemisinin and its derivatives were reported to possess strong regulatory effects on inflammation and autoimmune diseases. This study was designed to examine the therapeutic effects and underlying mechanisms of SM934, a water-soluble artemisinin analogue, on lupus-prone female NZB × NZW F(1) mice. METHODOLOGY/PRINCIPAL FINDINGS: NZB/W F(1) mice were treated orally with SM934 for 3 or 6 months respectively to investigate the effect on clinical manifestations and immunological correlates.

Author(s): 
Hou, Li-Fei
He, Shi-Jun
Li, Xin
Wan, Chun-Ping
Yang, Yang
Zhang, Xiao-Hui
He, Pei-Lan
Zhou, Yu
Zhu, Feng-Hua
Yang, Yi-fu
Li, Ying
Tang, Wei
Zuo, Jian-ping
Publication Title: 
Proceedings of the National Academy of Sciences of the United States of America

In (NZB x NZW)F(1) (B/W) mice, moderate caloric intake [10 kcal (41.8 kJ) per day] from the time of weaning was associated with maintenance of lower body weight, greater capacity of spleen cells to be stimulated with T-cell mitogens, and better preserved capacity to generate cytotoxic cells in response to in vitro and in vivo stimulation with allogeneic tumor cells. Plaque-forming cell response to sheep erythrocytes was also well maintained in animals on the restricted diets when sensitization was accomplished either in vitro or in vivo.

Author(s): 
Fernandes, G.
Friend, P.
Yunis, E. J.
Good, R. A.
Publication Title: 
The American Journal of Pathology

Mice of the autoimmune, lymphoproliferative strain MRL/lpr and the congenic, nonlymphoproliferative strain MRL/n were fed one of six diets from weaning on-ward. These mice were sacrificed at 3 or 5 months of age. Low fat diets resulted in lower cholesterol and higher triglyceride levels than did cholesterol-containing high-fat diets. Caloric restriction of MRL/lpr mice was associated with an increased plaque-forming cell response to trinitrophenylated polyacrylamide beads, less lymphoproliferation, and less severe glomerulonephritis.

Author(s): 
Mark, D. A.
Alonso, D. R.
Quimby, F.
Thaler, H. T.
Kim, Y. T.
Fernandes, G.
Good, R. A.
Weksler, M. E.
Publication Title: 
African journal of traditional, complementary, and alternative medicines: AJTCAM / African Networks on Ethnomedicines

The objective of the study was to investigate the effectiveness and efficacy of the randomized, parallel, and controlled trial of Traditional Chinese Medicine, general acteoside of Rehmanniae leaves, compared with piperazine ferulate in the treatment of primary chronic glomerulonephritis. Rehmanniae leaves and piperazine ferulate can reduce proteinuria and erythrocyturia effectively in the treatment of primary chronic glomerulonephritis.

Author(s): 
Qiu, HongYu
Fan, WenXing
Fu, Ping
Zuo, Chuan
Feng, Ping
Liu, Fang
Zhou, Li
Chen, Feng
Zhong, Hui
Liang, YaPing
Shi, Mei
Publication Title: 
American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation

BACKGROUND: Abelmoschus manihot, a single medicament of traditional Chinese medicine, has been widely used to treat kidney disease. This is the first randomized controlled clinical trial to assess its efficacy and safety in patients with primary glomerular disease. STUDY DESIGN: Prospective, open-label, multicenter, randomized, controlled, clinical trial. SETTING & PARTICIPANTS: From May 2010 to October 2011, a total of 417 patients with biopsy-proven primary glomerular disease from 26 hospitals participated in the study.

Author(s): 
Zhang, Li
Li, Ping
Xing, Chang-ying
Zhao, Jiu-yang
He, Ya-ni
Wang, Jian-qin
Wu, Xiong-fei
Liu, Zhang-suo
Zhang, Ai-ping
Lin, Hong-li
Ding, Xiao-qiang
Yin, Ai-ping
Yuan, Fa-huan
Fu, Ping
Hao, Li
Miao, Li-ning
Xie, Ru-juan
Wang, Rong
Zhou, Chun-hua
Guan, Guang-ju
Hu, Zhao
Lin, Shan
Chang, Ming
Zhang, Miao
He, Li-qun
Mei, Chang-lin
Wang, Li
Chen, Xiangmei
Subscribe to RSS - Glomerulonephritis